Role of herbal medicines to treat the symptoms of COVID-19 disease
Journal Title: TMR Clinical Research - Year 2021, Vol 4, Issue 2
Abstract
The need for effective therapeutic options for patients has received increasing attention in response to the prevalence of COVID 19. Although there are several options for the prevent of COVID-19, including vaccines, monoclonal antibodies, oligonucleotide-based therapies, peptides, and interferon therapies, no treatment for coronaviruses has yet been approved.
Authors and Affiliations
Mohammad Ali Zakeri1, Mahlagha Dehghan2*
Keywords
Related Articles
- EP ID EP695492
- DOI 10.12032/TMRCR20210522009
- Views 113
- Downloads 0
A case of myelodysplastic syndromes with initial symptom of erythra
Myelodysplastic syndrome (MDS) is a malignant clonal disease of human hematopoietic stem cells. In this paper, a case of MDS with fever and rash as the first symptom was reported in our hospital, and the related literatu...
Evaluation of autophagy-related genes and lncRNAs signature for prognositic prediction in thyroid carcinoma via bioinformatics analysis
Autophagy plays a significant role in the pathogenesis and prognosis of thyroid carcinoma. The role of autophagy-related genes and long non-coding RNAs, as well as the risk model of thyroid carcinoma patients were in...
Optimal cut-off and assessment of survival days are needed in risk factors for COVID-19 mortality
We recently read the study published on The Lancet by Dr. Zhou and colleagues, entitled “Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study”, wi...
Bibliometric analysis of nursing studies on Corona Virus Disease 2019 in China
Objective: To analysis the current status and research focus of Corona Virus Disease 2019 (COVID-19) nursing research in China. Methods: China National Knowledge Infrastructure (CNKI), WanFang, Chinese Scientific Journal...
Insight into the post-hospital syndrome
After hospitalization, the patient faces a brief fragile period of susceptibility to disease and a high incidence of adverse events (re-admission or death, etc.), which is described by cardiologist Harlan M.Krumholz as p...